Skip to content
AgingResearch.News app

AgingResearch.NewsFree on Google Play

Open app
AgingResearch.News
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved
Join freeSign inSign inSign in
AgingResearch.NewsJoin free

Penetrating Crohn's disease

There is 1 paper on penetrating Crohn's disease in aging research: 1 observational study in people.

Disease

1 paper studies it

See all 1 papers on penetrating Crohn's disease

  • Humans1

Latest

Inflammatory Bowel Diseases·Feb 27

Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease

Case-control study of 64 peopleCrohn's disease
Paper

Related

  • 5-aminosalicylates1
  • Crohn's colitis1
  • Crohn's disease1
  • Crohn's-related abscesses1
  • Biologics1
  • Bowel surgery1
  • Cryptococcal meningitis1
  • Extraintestinal manifestations1
  • Ileocolonic Crohn's disease1
  • Immunomodulators1
  • Immunomodulators + biologics1
  • Perianal Crohn's disease1
  • Pneumonia1
  • Serious therapy-related infectious complications1
  • Staphylococcal septicemia1
  • Steroids1
FooterIn your assistantComparePrivacyTermsAboutStandardsContactRSSPricingFollow on X© 2026 AgingResearch.News
Sidebar

    Join AgingResearch.News

    Free: every story, saved papers, follows, the weekly email and 3 questions a day to Ask.

    Continue with email

    By continuing, you agree to our Terms and Privacy Policy.

    News

    See allSee all news
    Novartis' pelacarsen lowers Lp(a) 78% without reducing cardiovascular events in phase 3TrialsLifespan Magazine +4Novartis' pelacarsen lowers Lp(a) 78% without reducing cardiovascular events in phase 3Pelacarsen lowers Lp(a) 78% but shows no cardiovascular benefit in HORIZON trialConferenceAHA Scientific Sessions 2026 +1Pelacarsen lowers Lp(a) 78% but shows no cardiovascular benefit in HORIZON trialGLP-1–glucagon agonist survodutide shows no increased cardiovascular risk in high-risk adults with obesityTrialsThe Lancet +2GLP-1–glucagon agonist survodutide shows no increased cardiovascular risk in high-risk adults with obesity

    Trials

    See allSee all trials
    The Effect of Walking on FrailtyResults posted Nov 2, 2026, Northwestern UniversityModulation Effects of Baduanjin Exercise on Subjective Cognitive DeclineResults posted Nov 6, 2026, Massachusetts General HospitalFinnish Geriatric Intervention Study to Prevent Cognitive Impairment and DisabilityCompleted Oct 28, 2026, University of Eastern Finland

    Trending

    See allSee all trending stories
    ExenatideInterventionExenatide lowered protein-based age scores in people6-shogaolIntervention6-Shogaol restores bone-forming ability in aged mouse cellsLY3437943InterventionFirst trial results posted: A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or…Aldosterone synthase inhibitorsIntervention9 papers in two weeks, 1 in the two months beforeLonelinessDisease23 papers in two weeks, usually 6Cellular senescenceProcessProtein loss reduced signs of senescence in mouse fat tissue, and 1 more story this week

    Topics

    See allSee all topics
    Mechanisms415Interventions1,301Biomarkers859Populations1,203AI & data194Industry & policy27SupplementsPeptidesProtocols
    Footer
    • In your assistant
    • Compare
    • Privacy
    • Terms
    • About
    • Standards
    • Contact
    • RSS
    • Follow on X
    • © 2026 AgingResearch.News